Post-approval studies (Phase 4)UnknownNCT02964715What this trial is testingThe Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 DiabetesWho this might be right forType2 DiabetesNAFLD University of Malaya 25
Post-approval studies (Phase 4)Study completedNCT03910361What this trial is testingEfficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesWho this might be right forType2 DiabetesNon-Alcoholic Fatty Liver Disease Dong-A ST Co., Ltd. 51
Not applicableLooking for participantsNCT05697991What this trial is testingNon-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes MellitusWho this might be right forNonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus King Saud University 1,000
Not applicableStudy completedNCT05844137What this trial is testingImproving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 DiabetesWho this might be right forNAFLDDiabetes Mellitus Duke University 10
Post-approval studies (Phase 4)Study completedNCT02303730What this trial is testingExenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2Non-alcoholic Fatty Liver Disease Fudan University 76
Not applicableStudy completedNCT04182646What this trial is testingEffect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver DiseaseWho this might be right forNon-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisObesity+1 more Asian Institute of Gastroenterology, India 36
Testing effectiveness (Phase 2)Study completedNCT00633282What this trial is testingRole of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty Liver Disease Xin Gao 184
Not applicableStudy completedNCT05550688What this trial is testingWeight Gain After Smoking Cessation and NAFLDWho this might be right forNonalcoholic Fatty Liver DiseaseType 2 Diabetes Ningbo No. 1 Hospital 12,941
Post-approval studies (Phase 4)Study completedNCT04910178What this trial is testingFollow-up of NAFLD Patients With MRI-PDFFWho this might be right forDiabetes Type 2NAFLD Asmaa Abdelfattah Elsayed 80
Post-approval studies (Phase 4)Looking for participantsNCT05644717What this trial is testingEffect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLDWho this might be right forLiver FatLiver FibrosisGlycemic Control+3 more Getz Pharma 164
Testing effectiveness (Phase 2)Study completedNCT00323414What this trial is testingPolyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverWho this might be right forFatty Liver National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 37
Not applicableNot Yet RecruitingNCT07336563What this trial is testingENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening StudyWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more Jarosław Drobnik 10,000
Not applicableStudy completedNCT03590626What this trial is testingEffect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseWho this might be right forNon Alcoholic Fatty Liver DiseaseType2 Diabetes Mellitus Medanta, The Medicity, India 60
Not applicableUnknownNCT05779644What this trial is testingEffects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusWho this might be right forMetforminObesity, AbdominalDiabetes Mellitus, Type 2+4 more RenJi Hospital 300
Not applicableStudy completedNCT02686476What this trial is testingEffect of Empagliflozin on Liver Fat Content in Patients With Type 2 DiabetesWho this might be right forNon Alcoholic Fatty Liver Disease Medanta, The Medicity, India 100
Not applicableLooking for participantsNCT03875625What this trial is testingChange of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionWho this might be right forNon-Alcoholic Fatty Liver DiseaseObesity, MorbidBrown Fat+4 more Chinese University of Hong Kong 80
Not applicableActive Not RecruitingNCT05275608What this trial is testingEffects of VLCKD in Metabolic SyndromeWho this might be right forDiabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity+1 more Azienda Ospedaliero Universitaria Maggiore della Carita 40
Not applicableNot Yet RecruitingNCT07713992What this trial is testingEfficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With SemaglutideWho this might be right forType 2 Diabetes Mellitus (T2DM)Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus Tianjin Medical University 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT05067621What this trial is testingSemaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseWho this might be right forType 2 Diabetes MellitusImpaired Glucose ToleranceNon-Alcoholic Fatty Liver Disease+1 more Yale University 60
Testing effectiveness (Phase 2)Study completedNCT03969719What this trial is testingStudy to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusWho this might be right forNon-alcoholic Steatohepatitis Pfizer 164